Folate and vitamin B12-related biomarkers in relation to brain volumes

Nutrients

Volumn 9, Issue 1, 2017, Pages

  van der Zwaluw, Nikita L ^a   Brouwer Brolsma, Elske M ^a   van de Rest, Ondine ^a   van Wijngaarden, Janneke P ^a   In ’t Veld, Paulette H ^a   Kourie, Daniella I ^a   Swart, Karin M A ^b   Enneman, Anke W ^c   van Dijk, Suzanne C ^c   van der Velde, Nathalie ^c,d   Kessels, Roy P C ^e,f   Smeets, Paul A M ^a,g   Kok, Frans J ^a   Dhonukshe Rutten, Rosalie A M ^a   de Groot, Lisette C P G M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f RADBOUD UNIVERSITY   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Brain volume; Folate; Grey matter; Holotranscobalamin; Homocysteine; Methylmalonic acid; Vitamin B12; White matter

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; CYANOCOBALAMIN; FOLIC ACID; HOLOTRANSCOBALAMIN; HOMOCYSTEINE; METHYLMALONIC ACID; PLACEBO; UNCLASSIFIED DRUG; TRANSCOBALAMIN;

AGED; ARTICLE; BLOOD ANALYSIS; BODY MASS; BRAIN SIZE; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GERIATRIC DEPRESSION SCALE; GRAY MATTER; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WHITE MATTER; ANATOMY AND HISTOLOGY; BLOOD; BRAIN; CROSS-SECTIONAL STUDY; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; NUTRITIONAL STATUS; ORGAN SIZE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; TANDEM MASS SPECTROMETRY;

AGED; BIOMARKERS; BODY MASS INDEX; BRAIN; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; METHYLMALONIC ACID; NUTRITIONAL STATUS; ORGAN SIZE; TANDEM MASS SPECTROMETRY; TRANSCOBALAMINS; VITAMIN B 12;

EID: 85008191240     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9010008     Document Type: Article

References (47)

1. Smith, A.D. The worldwide challenge of the dementias: A role for B vitamins and homocysteine? Food Nutr. Bull. 2008, 29, S143-S172. [CrossRef] [PubMed]
2. Sachdev, P.S., Valenzuela, M., Wang, X.L., Looi, J.C., Brodaty, H. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 2002, 58, 1539-1541. [CrossRef] [PubMed]
3. Morris, M.S. The role of B vitamins in preventing and treating cognitive impairment and decline. Adv. Nutr. 2012, 3, 801-812. [CrossRef] [PubMed]
4. Smith, A.D., Refsum, H. Vitamin B-12 and cognition in the elderly. Am. J. Clin. Nutr. 2009, 89, 707S-711S. [CrossRef] [PubMed]
5. Carmichael, O., Mungas, D., Beckett, L., Harvey, D., Tomaszewski Farias, S., Reed, B., Olichney, J., Miller, J., Decarli, C. MRI predictors of cognitive change in a diverse and carefully characterized elderly population. Neurobiol. Aging. 2012, 33, 83-95. [CrossRef] [PubMed]
6. Sizonenko, S.V., Babiloni, C., De Bruin, E.A., Isaacs, E.B., Jonsson, L.S., Kennedy, D.O., Latulippe, M.E., Mohajeri, M.H., Moreines, J., Pietrini, P., et al. Brain imaging and human nutrition: Which measures to use in intervention studies? Br. J. Nutr. 2013, 110 (Suppl 1), S1-S30. [CrossRef] [PubMed]
7. Vermeer, S.E., Van Dijk, E.J., Koudstaal, P.J., Oudkerk, M., Hofman, A., Clarke, R., Breteler, M.M. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann. Neurol. 2002, 51, 285-289. [CrossRef] [PubMed]
8. De Lau, L.M., Smith, A.D., Refsum, H., Johnston, C., Breteler, M.M. Plasma vitamin B12 status and cerebral white-matter lesions. J. Neurol. Neurosurg. Psychiatry 2009, 80, 149-157. [CrossRef] [PubMed]
9. Tangney, C.C., Aggarwal, N.T., Li, H., Wilson, R.S., Decarli, C., Evans, D.A., Morris, M.C. Vitamin B12, cognition, and brain MRI measures: A cross-sectional examination. Neurology 2011, 77, 1276-1282. [CrossRef] [PubMed]
10. Vogiatzoglou, A., Refsum, H., Johnston, C., Smith, S.M., Bradley, K.M., De Jager, C., Budge, M.M., Smith, A.D. Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology 2008, 71, 826-832. [CrossRef] [PubMed]
11. De Lau, L.M., Refsum, H., Smith, A.D., Johnston, C., Breteler, M.M. Plasma folate concentration and cognitive performance: Rotterdam Scan Study. Am. J. Clin. Nutr. 2007, 86, 728-734. [PubMed]
12. Van Wijngaarden, J.P., Dhonukshe-Rutten, R.A., Van Schoor, N.M., Van Der Velde, N., Swart, K.M., Enneman, A.W., Van Dijk, S.C., Brouwer-Brolsma, E.M., Zillikens, M.C., Van Meurs, J.B., et al. Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence. BMC Geriatr. 2011, 11, 80. [CrossRef] [PubMed]
13. Van Wijngaarden, J.P., Swart, K.M., Enneman, A.W., Dhonukshe-Rutten, R.A., Van Dijk, S.C., Ham, A.C., Brouwer-Brolsma, E.M., Van Der Zwaluw, N.L., Sohl, E., Van Meurs, J.B., et al. Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial. Am. J. Clin. Nutr. 2014, 100, 1578-1586. [CrossRef] [PubMed]
14. Folstein, M.F., Folstein, S.E., Mchugh, P.R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12, 189-198. [CrossRef]
15. Almeida, O.P., Almeida, S.A. Short versions of the geriatric depression scale: A study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int. J. Geriatr. Psychiatry 1999, 14, 858-865. [CrossRef]
16. Garretsen, H. Probleemdrinken, Prevalentiebepaling, Beinvloedende Factoren en Preventiemogelijkheden, Theoretische Overwegingen en Onderzoek in Rotterdam (Dissertation in Dutch), Swets and Zeitlinger: Lisse, The Netherlands, 1983.
17. Stel, V.S., Smit, J.H., Pluijm, S.M., Visser, M., Deeg, D.J., Lips, P. Comparison of the LASA Physical Activity Questionnaire with a 7-day diary and pedometer. J. Clin. Epidemiol. 2004, 57, 252-258. [CrossRef] [PubMed]
18. Jenkinson, M., Beckmann, C.F., Behrens, T.E., Woolrich, M.W., Smith, S.M. FSL. Neuroimage 2012, 62, 782-790. [CrossRef] [PubMed]
19. Ashburner, J., Friston, K.J. Unified segmentation. Neuroimage 2005, 26, 839-851. [CrossRef] [PubMed]
20. Van Wijngaarden, J.P. Bones, Brains and B-Vitamins. Ph.D. Thesis, Wagenigen University, Wageningen, The Netherlands, 2013.
21. Van Der Zwaluw, N.L., Dhonukshe-Rutten, R.A., Van Wijngaarden, J.P., Brouwer-Brolsma, E.M., Van De Rest, O., In ’T Veld, P.H., Enneman, A.W., Van Dijk, S.C., Ham, A.C., Swart, K.M., et al. Results of 2-year vitamin B treatment on cognitive performance: Secondary data from an RCT. Neurology 2014, 83, 2158-2166. [CrossRef] [PubMed]
22. Ford, A.H., Almeida, O.P. Effect of Homocysteine Lowering Treatment on Cognitive Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Alzheimers Disease 2012, 29, 133-149.
23. Doets, E.L., VanWijngaarden, J.P., Szczecinska, A., Dullemeijer, C., Souverein, O.W., Dhonukshe-Rutten, R.A., Cavelaars, A.E., Van ’T Veer, P., Brzozowska, A., De Groot, L.C. Vitamin B12 Intake and Status and Cognitive Function in Elderly People. Epidemiol. Rev. 2013, 35, 2-21. [CrossRef] [PubMed]
24. Douaud, G., Refsum, H., De Jager, C.A., Jacoby, R., Nichols, T.E., Smith, S.M., Smith, A.D. Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proc. Natl. Acad. Sci. USA 2013, 110, 9523-9528. [CrossRef] [PubMed]
25. Fox, N.C., Crum, W.R., Scahill, R.I., Stevens, J.M., Janssen, J.C., Rossor, M.N. Imaging of onset and progression of Alzheimer’s disease with voxel-compression mapping of serial magnetic resonance images. Lancet 2001, 358, 201-205. [CrossRef]
26. Jack, C.R., Jr., Shiung, M.M., Gunter, J.L., O’brien, P.C., Weigand, S.D., Knopman, D.S., Boeve, B.F., Ivnik, R.J., Smith, G.E., Cha, R.H., et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004, 62, 591-600. CrossRef] [PubMed]
27. Sluimer, J.D., Van Der Flier, W.M., Karas, G.B., Fox, N.C., Scheltens, P., Barkhof, F., Vrenken, H. Whole-brain atrophy rate and cognitive decline: Longitudinal MR study of memory clinic patients. Radiology 2008, 248, 590-598. [CrossRef] [PubMed]
28. Brouwer-Brolsma, E.M., Van Der Zwaluw, N.L., Van Wijngaarden, J.P., Dhonukshe-Rutten, R.A., In ’T Veld, P.H., Feskens, E.J., Smeets, P.A., Kessels, R.P., Van De Rest, O., De Groot, L.C. Higher Serum 25-Hydroxyvitamin D and Lower Plasma Glucose Are Associated with Larger Gray Matter Volume but Not with White Matter or Total Brain Volume in Dutch Community-Dwelling Older Adults. J. Nutr. 2015, 145, 1817-1823. [CrossRef] [PubMed]
29. Brouwer-Brolsma, E.M., Dhonukshe-Rutten, R.A., Van Wijngaarden, J.P., Van De Zwaluw, N.L., In ’T Veld, P.H., Wins, S., Swart, K.M., Enneman, A.W., Ham, A.C., Van Dijk, S.C., et al. Cognitive performance: A cross-sectional study on serum vitamin d and its interplay with glucose homeostasis in Dutch older adults. J. Am. Med. Dir. Assoc. 2015, 16, 621-627. [CrossRef] [PubMed]
30. Selhub, J., Morris, M.S., Jacques, P.F., Rosenberg, I.H. Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency. Am. J. Clin. Nutr. 2009, 89, 702S-706S. [CrossRef] [PubMed]
31. Moore, E.M., Ames, D., Mander, A.G., Carne, R.P., Brodaty, H., Woodward, M.C., Boundy, K., Ellis, K.A., Bush, A.I., Faux, N.G., et al. Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: Combined data from three cohorts. J. Alzheimers Disease 2014, 39, 661-668.
32. Morris, M.S., Selhub, J., Jacques, P.F. Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the framingham heart study. J. Am. Geriatr. Soc. 2012, 60, 1457-1464. [CrossRef] [PubMed]
33. Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Hebert, L.E., Scherr, P.A., Schneider, J.A. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch. Neurol. 2005, 62, 641-645. [CrossRef] [PubMed]
34. Yang, L.K., Wong, K.C., Wu, M.Y., Liao, S.L., Kuo, C.S., Huang, R.F. Correlations between folate, B12, homocysteine levels, and radiological markers of neuropathology in elderly post-stroke patients. J. Am. Coll. Nutr. 2007, 26, 272-278. [CrossRef] [PubMed]
35. Chanarin, I. The Megaloblastic Anaemias, 3rd ed., Blackwell Scientific Publications: Oxford, UK, 1990.
36. Den Heijer, T., Vermeer, S.E., Clarke, R., Oudkerk, M., Koudstaal, P.J., Hofman, A., Breteler, M.M. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003, 126, 170-175. [CrossRef] [PubMed]
37. Seshadri, S., Wolf, P.A., Beiser, A.S., Selhub, J., Au, R., Jacques, P.F., Yoshita, M., Rosenberg, I.H., D’agostino, R.B., Decarli, C. Association of plasma total homocysteine levels with subclinical brain injury: Cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch. Neurol. 2008, 65, 642-649. [CrossRef] [PubMed]
38. Williams, J.H., Pereira, E.A., Budge, M.M., Bradley, K.M. Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. Age Ageing 2002, 31, 440-444. [CrossRef] [PubMed]
39. Smith, A.D., Smith, S.M., De Jager, C.A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K.M., Jacoby, R., Refsum, H. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS ONE 2010, 5, e12244. [CrossRef] [PubMed]
40. Raz, N., Rodrigue, K.M. Differential aging of the brain: Patterns, cognitive correlates and modifiers. Neurosci. Biobehav. Rev. 2006, 30, 730-748. [CrossRef] [PubMed]
41. Popp, J., Lewczuk, P., Linnebank, M., Cvetanovska, G., Smulders, Y., Kolsch, H., Frommann, I., Kornhuber, J., Maier, W., Jessen, F. Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer’s disease. J. Alzheimers Disease 2009, 18, 819-828.
42. Zhang, C.E., Tian, Q., Wei, W., Peng, J.H., Liu, G.P., Zhou, X.W., Wang, Q., Wang, D.W., Wang, J.Z. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Neurobiol. Aging 2008, 29, 1654-1665. [CrossRef] [PubMed]
43. Wald, D.S., Law, M., Morris, J.K. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 2002, 325, 1202. [CrossRef] [PubMed]
44. Stojsavljevic, N., Levic, Z., Drulovic, J., Dragutinovic, G. A 44-month clinical-brain MRI follow-up in a patient with B12 deficiency. Neurology 1997, 49, 878-881. [CrossRef] [PubMed]
45. Scalabrino, G. Cobalamin (vitamin B(12)) in subacute combined degeneration and beyond: Traditional interpretations and novel theories. Exp. Neurol. 2005, 192, 463-479. [CrossRef] [PubMed]
46. Brouwer-Brolsma, E.M., Dhonukshe-Rutten, R.A., Van Wijngaarden, J.P., Zwaluw, N.L., Velde, N., De Groot, L.C. Dietary Sources of Vitamin B-12 and Their Association with Vitamin B-12 Status Markers in Healthy Older Adults in the B-PROOF Study. Nutrients 2015, 7, 7781-7797. [CrossRef] [PubMed]
47. Bates, C.J., Prentice, A., Van Der Pols, J.C., Walmsley, C., Pentieva, K.D., Finch, S., Smithers, G., Clarke, P.C. Estimation of the use of dietary supplements in the National Diet and Nutrition Survey: People aged 65 years and Over. An observed paradox and a recommendation. Eur. J. Clin. Nutr. 1998, 52, 917-923. [CrossRef] [PubMed]